v3 Template
C

Cyclana Bio

Biotechnology / Women's Health ~40 employees
Founded
--
Employees (Est.)
~40
4 leaders known
Total Funding
$5.0M
Funding Rounds
1
Last Funding
2025-10-20

About Cyclana Bio

Cyclana Bio, formerly known as Cycle Therapeutics, is dedicated to advancing women's health by harnessing tissue and matrix biology to develop innovative treatments, starting with a focus on finding a cure for endometriosis. Their mission is to uncover mechanisms in women's health and disease, using human tissue data and models to revolutionize therapeutic discovery.

Products & Services

Women's Health Research and Treatments:Developing novel health insights and treatments for women's health conditions, particularly endometriosis, by stratifying conditions, building physiological assays, and targeting disease drivers using menstrual fluid.

Specialties

Endometriosis Research Tissue and Matrix Biology Therapeutic Discovery Menstrual Fluid Analysis Physiological Assays

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Pre-Seed
T: -
FT: Pre-Seed 		A: 5000000
MR: -
FA: £5M
FAN: 5000000 		D: 2025-10-20
FD: 2025-10-20 		5 investors
Pre-Seed Latest
2025-10-20
$5.0M
5 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

L

Léa Wenger

CEO & Co-Founder

K

Kevin Chalut

Physical Biologist, entrepreneur, CSO, founder

LinkedIn (Pro only)
A

Amy Lock

Founding Scientist

LinkedIn (Pro only)
T

Tom Wyatt

Founding Scientist

View 1 more team members with Pro

Unlock Full Team Directory

Recent News

Cyclana Bio Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology / Women's Health
Company Size
~40 employees (est.)

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro